Advance of second-line chemotherapy in advanced non-small cell lung cancer

Advance of second-line chemotherapy in advanced non-small cell lung cancer

There is a temporal disease-free period after 1st line chemotherapy in advanced non-small cell lung cancer (NSCLC), most of patients need 2nd line chemotherapy. The recommended drugs in the 2nd line were docetaxel, pemetrexed and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs...

Full description

Bibliographic Details
Main Author: Li ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Antineoplastic combined chemotherapy protocols
Docetaxel
Pemetexem
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.01.002&path%5B%5D=5

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.01.002&path%5B%5D=5

Similar Items